Still, when comparing tumor burden and location (e.g. M1a vs. M1b vs. M1c) between the three groups, one has to keep in mind that staging was done with PSMA-PET scan for patients prior to Lu-PSMA. This evidence concerns the gene FOLH1 and neoplasm.